Preferred Label : Bivalent Vaccines;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3415710/fr/strategie-de-vaccination-contre-la-covid-19-place-du-vaccin-comirnaty-bivalent-original/baba-4-5-10-g/dose-dans-la-strategie-de-rappel-des-enfants-de-5-a-11-ans-revolus-a-risque-de-forme-grave
2024
France
public health guidelines
Vaping
Offspring
Severity Four Out of Five
risk
Recollect
child, nos
severe
health planning guidelines
Eleven
COVID-19 Vaccines
Loss of Chromosome 11
vaccination
Callback
Reminder
Per Hundred Thousand
Bivalent Vaccines
Serious Risk
Recommendation
Strategy
Per Ten Thousand
Vaccination
Child
preventive immunization/medication
child
Vaccine
Placement
vaccination
Booster
vaccinia virus vaccine
Autonomic Nervous System

---
https://ansm.sante.fr/actualites/epi-phare-publie-dans-le-nejm-les-resultats-dune-etude-qui-montre-quil-ny-a-pas-daugmentation-du-risque-devenement-cardiovasculaire-grave-avec-les-vaccins-bivalents-contre-le-covid-19
2023
false
false
false
France
French
drug information
COVID-19 Vaccines
Bivalent Vaccines
mRNA Vaccines
cardiovascular diseases

---
https://www.has-sante.fr/jcms/p_3367933/fr/place-du-vaccin-contre-la-covid-19-spikevax-bivalent-original/omicron-ba-1
2022
false
false
false
France
COVID-19
COVID-19 Vaccines
public health guidelines
Bivalent Vaccines
vaccination
preventive immunization/medication
health planning guidelines
Vaccinia
Vaccins
vaccine, nos

---
https://www.has-sante.fr/jcms/p_3367937/fr/place-des-vaccins-contre-la-covid-19-cominarty-bivalents-original/omicron-ba-1-et-original/omicron-ba-4-5
2022
false
false
false
France
COVID-19
COVID-19 Vaccines
Tozinameran
Riltozinameran
public health guidelines
health planning guidelines
vaccination
vaccine, nos
vaccinia, nos
Vaccins
Bivalent Vaccines
vaccination, nos
preventive immunization/medication
Vaccinia

---
https://www.inspq.qc.ca/publications/3268-administration-vaccin-bivalent-vaccin-monovalent-COVID-19
2022
Canada
public health guidelines
COVID-19
Bivalent Vaccines
preventive immunization/medication
Vaccinia
COVID-19 Vaccines
vaccinia
vaccinia virus vaccine
persons
vaccination
vaccination
Vaccins
Administration
organization and administration
vaccines
administration

---
https://assurance-maladie.ameli.fr/etudes-et-donnees/2022-vaccins-bivalents-monovalents-arn-messager-covid-19
2022
France
technical report
messenger rna
France
COVID-19 Vaccines
France
vaccine, nos
France
vaccination
COVID-19
preventive immunization/medication
Bivalent Vaccines
RNA Vaccine
france
vaccinia, nos
Vaccins
RNA, messenger
french
vaccination, nos
Vaccinia
mRNA Vaccines
France

---
https://www.canada.ca/content/dam/phac-aspc/documents/services/immunization/national-advisory-committee-on-immunization-naci/recommandations-utilisation-vaccins-arnm-bivalents-contre-covid-19-contenant-variant-omicron.pdf
2022
false
false
false
Canada
COVID-19
COVID-19 Vaccines
public health guidelines
Bivalent Vaccines
Off-Label use
mRNA Vaccines
vaccinia, nos
vaccination
vaccine, nos
preventive immunization/medication
Vaccinia
messenger rna
Vaccins
vaccination, nos

---
Distribution of SPIKEVAX Bivalent (elasomeran/imelasomeran) COVID-19 Vaccine with English-only Vial and Carton Labels
https://recalls-rappels.canada.ca/fr/avis-rappel/distribution-du-vaccin-spikevax-bivalent-elasomeranimelasomeran-contre-covid-19-avec
2022
false
false
false
Canada
French
English
COVID-19 Vaccines
COVID-19
vaccination
drug information
canada
COVID-19 Vaccines
immunization, secondary
mRNA Vaccines
Bivalent Vaccines
covid-19, RNA-based vaccine

---
https://www.has-sante.fr/jcms/p_3383749/fr/strategie-de-vaccination-contre-la-covid-19-place-du-vaccin-spikevax-bivalent-original-/-omicron-ba-4/ba-5-arnm-1273-222
2022
France
public health guidelines
rna, messenger
Bivalent Vaccines
vaccination, nos
Vaccins
vaccination
messenger rna
health planning guidelines
Vaccinia
COVID-19 Vaccines
preventive immunization/medication
vaccine, nos
COVID-19
vaccination

---
Nous contacter.
04/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.